Forest Ends Phenomix Partnership, But Says Its Many Deals Are Bearing Fruit

In same-day earnings call, the specialty pharma company reported year-end fiscal 2010 sales of $4.2 billion, up 6.9 percent.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet